Estimating the impact of healthcare-associated infections on length of stay and costs

Clinical Microbiology and Infection

Volumn 16, Issue 12, 2010, Pages 1729-1735

  De Angelis, G ^a,b   Murthy, A ^a,c   Beyersmann, J ^d   Harbarth, S ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b CATHOLIC UNIVERSITY   (Italy)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Burden; Economics; Infection; Methodology; Multistate; Review

Indexed keywords

HEALTH CARE UTILIZATION; HEALTHCARE ASSOCIATED INFECTION; HOSPITAL COST; HOSPITAL INFECTION; HUMAN; LENGTH OF STAY; MORBIDITY; MORTALITY; PRIORITY JOURNAL; REVIEW;

EID: 78349294870     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03332.x     Document Type: Review

References (46)

1. Saleh SS, Callan M, Therriault M et al. The cost impact of hospital-acquired conditions among critical care patients. Med Care 2010; 48: 518-526.
2. Medicare Program. Changes to the hospital inpatient prospective payment systems and fiscal year 2008 rates. Fed Regist 2007; 72: 47379-473428.
3. Graves N, Harbarth S, Beyersmann J et al. Estimating the cost of health care-associated infections: mind your p's and q's. Clin Infect Dis 2010; 50: 1017-1021.
4. Nathwani D. Health economic issues in the treatment of drug-resistant serious Gram-positive infections. J Infect 2009; 59 (suppl 1): S40-S50.
5. Samore M, Harbarth S. A methodologically focused review of the literature in hospital epidemiology and infection control. In: Mayhall CG, ed. Hospital epidemiology and infection control, 3rd edn. Philadelphia, PA: Lippincott Williams & Wilkins, 2004; 1645-1656.
6. Stone PW, Larson E, Kawar LN. A systematic audit of economic evidence linking nosocomial infections and infection control interventions: 1990-2000. Am J Infect Control 2002; 30: 145-152.
7. Stone PW, Braccia D, Larson E. Systematic review of economic analyses of health care-associated infections. Am J Infect Control 2005; 33: 501-509.
8. Department of Health, UK. Hospital infection control: guidance on the control of infections in hospitals. HSG (95)10. London, UK: Department of Health, 1995.
9. Plowman RP, Graves N, Griffin M et al. The socio-economic burden of hospital acquired infection. London, UK: Public Health Laboratory Service, 1999. Available at: (last accessed 16 September 2010).
10. Barber JA, Thompson SG. Analysis and interpretation of cost data in randomized controlled trials: review of published studies. BMJ 1998; 317: 1195-1200.
11. Graves N. Economics and preventing hospital-acquired infection. Emerg Infect Dis 2004; 10: 561-566.
12. Beyersmann J, Gastmeier P, Grundmann H et al. Use of multistate models to assess prolongation of intensive care unit stay due to nosocomial infection. Infect Control Hosp Epidemiol 2006; 27: 493-499.
13. Graves N, Weinhold D, Tong E et al. Effect of healthcare-acquired infection on length of hospital stay and cost. Infect Control Hosp Epidemiol 2007; 28: 280-292.
14. Schulgen G, Schumacher M. Estimation of prolongation of hospital stay attributable to nosocomial infections: new approaches based on multistate models. Lifetime Data Anal 1996; 2: 219-240.
15. Schulgen G, Kropec A, Kappstein I, Daschner F, Schumacher M. Estimation of extra hospital stay attributable to nosocomial infections: heterogeneity and timing of events. J Clin Epidemiol 2000; 53: 409-417.
16. Barnett AG, Batra R, Graves N et al. Using a longitudinal model to estimate the effect of methicillin-resistant Staphylococcus aureus infection on length of stay in intensive care unit. Am J Epidemiol 2009; 170: 1186-1194.
17. Beyersmann J, Gastmeier P, Wolkewitz M et al. An easy mathematical proof showed that time-dependent bias inevitably leads to biased effect estimation. J Clin Epidemiol 2008; 61: 1216-1221.
18. Anderson DJ, Kaye KS, Chen LF et al. Clinical and financial outcomes due to methicillin resistant Staphylococcus aureus surgical site infection: a multi-center matched outcomes study. PLoS ONE 2009; 4: e830.
19. Haley RW. Measuring the costs of nosocomial infections: methods for estimating economic burden on the hospital. Am J Med 1991; 91 (suppl 3B): 32s-38s.
20. Eber MR, Laxminarayan R, Perencevich EN et al. Clinical and economic outcomes attributable to health care-associated sepsis and pneumonia. Arch Intern Med 2010; 170: 347-353.
21. Resch A, Wilke M, Fink C. The cost of resistance: incremental cost of methicillin-resistant Staphylococcus aureus (MRSA) in German hospitals. Eur J Health Econ 2009; 10: 287-297.
22. Vrijens F, Hulstaert F, Van de Sande S et al. Hospital-acquired, laboratory-confirmed bloodstream infections: linking national surveillance data to clinical and financial hospital data to estimate increased length of stay and healthcare costs. J Hosp Infect 2010; 75: 158-162.
23. Mauldin PD, Salgado CD, Hansen IS et al. Attributable hospital cost and length of stay associated with health care-associated infections caused by antibiotic-resistant gram-negative bacteria. Antimicrob Agents Chemother 2010; 54: 109-115.
24. Weigelt JA, Lipsky BA, Tabak YP et al. Surgical site infections: causative pathogens and associated outcomes. Am J Infect Control 2010; 38: 112-120.
25. Oztoprak N, Cevik MA, Akinci E et al. Risk factors for ICU-acquired methicillin-resistant Staphylococcus aureus infections. Am J Infect Control 2006; 34: 1-5.
26. Marshall C, Wolfe R, Kossmann T et al. Risk factors for acquisition of methicillin-resistant Staphylococcus aureus (MRSA) by trauma patients in the intensive care unit. J Hosp Infect 2004; 57: 245-252.
27. Graffunder EM, Venezia RA. Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. J Antimicrob Chemother 2002; 49: 999-1005.
28. Moffitt R. Program evaluation with nonexperimental data. Eval Rev 1991; 15: 291-314.
29. Plasmans J. Modern linear and nonlinear econometrics. Generalized methods of moments. New York: Springer, 2006.
30. Plowman RP, Graves N, Griffin MAS et al. The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed. J Hosp Infect 2001; 47: 198-209.
31. Graves N, Weinhold D, Roberts JA. Correcting for bias when estimating the cost of hospital-acquired infection: an analysis of lower respiratory tract infections in non-surgical patients. Health Econ 2005; 14: 755-761.
32. Graves N, Halton K, Jarvis WR. Economics and preventing healthcare-acquired infection. New York: Springer Science+Business Media, 2009.
33. Blot S, Vandewoude K, Colardyn F. Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: a matched cohort study. Intensive Care Med 2003; 29: 471-475.
34. Blot S, De Bacquer D, Hoste E et al. Influence of matching for exposure time on estimates of attributable mortality caused by nosocomial bacteremia in critically ill patients. Infect Control Hosp Epidemiol 2005; 26: 352-356.
35. Eggimann P, Harbarth S, Constantin MN et al. Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care. Lancet 2000; 355: 1864-1868.
36. Harbarth S, Fankhauser C, Schrenzel J et al. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA 2008; 299: 1149-1157.
37. Wolkewitz M, Beyersmann J, Gastmeier P et al. Efficient risk set sampling when a time-dependent exposure is present: matching for time to exposure versus exposure density sampling. Methods Inf Med 2009; 48: 438-443.
38. Perencevich EN, Stone PW, Wright SB et al Raising standards while watching the bottom line: making a business case for infection control. Infect Control Hosp Epidemiol 2007; 28: 1121-1133.
39. Mantel N, Byar D. Evaluation of response-time data involving transient states: an illustration using heart-transplant data. J Am Stat Assoc 1974; 69: 81-86.
40. Beyersmann J, Kneib T, Schumacher M et al. Nosocomial infection, length of stay, and time-dependent bias. Infect Control Hosp Epidemiol 2009; 30: 273-276.
41. Nguile-Makao M, Zahar JR, Francais A et al. Attributable mortality of ventilator-associated pneumonia: respective impact of main characteristics at ICU admission and VAP onset using conditional logistic regression and multi-state models. Intensive Care Med 2010; 36: 781-789.
42. Allignol A, Schumacher M, Beyersmann J. Estimating summary functional in multistate models with an application to hospital infection data. Comput Stat 2010; doi
43. Makuch R. Adjusted survival curve estimation using covariates. J Chronic Dis 1982; 35: 437-443.
44. R Development Core Team. R: a language and environment for statistical computing. Vienna, Austria, 2009. Available at: (last accessed 16 September 2010).
45. Wangler M, Beyersmann J, Schumacher M. changeLOS: an R-package for change in length of hospital stay based on the Aalen-Johansen estimator. R News 2006; 6: 31-35. Available at: (last accessed 16 September 2010).
46. Andersen PK, Keiding N. Multi-state models for event history analysis. Stat Methods Med Res 2002; 11: 91-115.